Cuba’s biotech sector crippled by systematic US sanctions, says expert
Mitchell Valdes-Sosa claims that U.S. sanctions are strangling Cuba's healthcare and biotechnology infrastructure by blocking essential income and supplies.
Mitchell Valdes-Sosa, one of the architects of Cuba’s biotechnology strategy, says U.S. sanctions are crippling Cuba’s healthcare and biotech sectors by choking off income, supplies and energy; despite worsening shortages and health outcomes, Cuba is prioritising key research and expanding international collaboration to keep its biotech industry functioning, he adds